Abstract:Background: Sufficient epidemiologic evidence shows an etiologic link between polycyclic aromatic hydrocarbons (PAH) exposure and lung cancer risk. While the genetic modifications have been found in PAH-exposed population, it is unclear whether gene-specific methylation involves in the process of PAHassociated biologic consequence. Methods: Sixty-nine PAH-exposedworkers and 59 control subjects were recruited. Using bisulfite sequencing, we examined the methylation status of p16 promoter in peripheral blood lymphocytes (PBL) from PAH-exposed workers and in benzo(a)pyrene (BaP)-transformed human bronchial epithelial (HBE) cells. The relationships between p16 methylation and the level of urinary 1-hydroxypyrene (1-OHP) or the frequency of cytokinesis block micronucleus (CBMN) were analyzed. Results:Comparedwith the control group, PAH-exposedworkers exhibited higher levels of urinary 1-OHP (10.62 vs. 2.52 mg/L), p16 methylation (7.95% vs. 1.14% for 22 "hot" CpG sites), and CBMN (7.28% vs. 2.92%) inPBLs. p16hypermethylation inPAH-exposedworkers exhibitedCpGsite specificity.Among the 35 CpG sites we analyzed, 22 were significantly hypermethylated. These 22 hypermethylated CpG sites were positively correlated to levels of urinary 1-OHP and CBMN in PBLs. Moreover, the hypermethylation and suppression of p16 expression was also found in BaP-transformed HBER cells. Conclusion: PAH exposure induced CpG site–specific hypermethylation of p16 gene. The degree of p16 methylation was associated with the levels of DNA damage and internal exposure. Impact: p16 hypermethylation might be an essential biomarker for the exposure to PAHs and for early diagnosis of cancer. Cancer Epidemiol Biomarkers Prev; 1–9. 2011 AACR.

CpGSite – Speci fi cHypermethylation of p 16 INK 4 a in Peripheral Blood Lymphocytes of PAH-Exposed Workers